WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the third quarter ended September 30, 2006 on Thursday, November 9, 2006 prior to the opening of the U.S. financial markets. A conference call will be held at 8:30 a.m. Eastern Time with Steven Rauscher, President and CEO, and other members of Oscient’s management team. The Company announced preliminary revenue results for the third quarter on October 11, 2006.
